Sign in New Account

The Summit

29th - 31st March 2010

NGP Summit 2010

Summit Venue
Hotel CampoReal Golf Resort & Spa, Portugal

The Next Generation Pharmaceutical Summit March 2010 will once again serve as an arena for senior level executives to engage in clear and focused dialogue with their peers and examine their management objectives in a relaxed and vibrant environment.

  • Previous Summits

Summit Update

Get the latest summit news sent to your email or mobile.

Why Attend

The NGP Summit 2009 will serve as an arena for senior level executives to engage in a clear and focused dialogue with their peers to procure and examine their business and manufacturing objectives in real time.

GDS has elected more than 50 of the most well respected executives in the European pharmaceutical industry. The delegation gathers together in France to spend two days with their peers to network and share knowledge while assessing new technologies available in the marketplace.

Invitations are based on the investments these executives are currently making in the market. Many of these executives have worked closely with us through our NGP Report by contributing thought leadership and editorial content and are excited about working with us in the upcoming NGP Summit.

Each pharmaceutical executive will engage in a series of business meetings, contribute in facilitated roundtable discussions with peers and play an active role in structured and informal break-out sessions and moderated workshops.

Whilst there are sponsors in attendance, the programme is designed with the end-user in mind. The delegate attendance is comprised of the most well respected executives in the pharmaceutical industry, and the meeting format is designed to surpass the traditional exchange of business cards and allow executives to communicate on a personal level whilst ultimately gaining a better understanding of how to address their most common challenges.

Testimonials

"This meeting provided an excellent opportunity to meet key thinkers in the clinical study Pharma space and to present the contributions of our technology to them."

Scott Watson, Aperio